Seoulin Bioscience Co Ltd Profitability Analysis: Margins, Return on Capital, Free Cash Flow, and More - Seoulin Bioscience Co Ltd

Watchlist Manager

Watchlist

Price: 4 055 KRW -1.82% Market Closed

Market Cap: ₩37.7B

S	Seoulin Bioscience Co Ltd KOSDAQ:038070	KR
O	Organizacion Soriana SAB de CV SWB:OSOB	MX
	Batavia Prosperindo Internasional Tbk PT IDX:BPII	ID
I	IHI Corp DUS:IWJ	JP
C	Coda Minerals Ltd ASX:COD	AU
	Shift Inc F:7CZ	JP

Profitability Summary

Seoulin Bioscience Co Ltd's profitability score is Hidden . We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.

Healthy Gross Margin

21%

Sustainable 3Y Average Gross Margin

23%

Declining Gross Margin

24% > 21%

Low Operating Margin

Low 3Y Average Operating Margin

Declining Operating Margin

4% > 0%

Low Net Margin

Low 3Y Average Net Margin

Declining Net Margin

4% > 1%

Negative Free Cash Flow Margin

Negative 3Y Average Free Cash Flow Margin

-1%

Free Cash Flow Margin is Increasing

View All Checks

We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.

Healthy Gross Margin

21%

Sustainable 3Y Average Gross Margin

23%

Declining Gross Margin

24% > 21%

Low Operating Margin

Low 3Y Average Operating Margin

Declining Operating Margin

4% > 0%

Low Net Margin

Low 3Y Average Net Margin